Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation.
about
Why pulsatility still matters: a review of current knowledgeA quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index.Early adverse events as predictors of 1-year mortality during mechanical circulatory support.The use of computational fluid dynamics in the development of ventricular assist devicesPreoperative patient optimization for mechanical circulatory supportSurvival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients.Right ventricular dysfunction following continuous flow left ventricular assist device placement in 51 patients: predicators and outcomesEvaluation of the HeartWare ventricular assist device Lavare cycle in a particle image velocimetry model and in clinical practice.Biventricular assist device terminates polymorphic ventricular tachycardia in giant cell myocarditisPerioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.Assessing pneumonia identification from time-ordered narrative reports.Acquired von Willebrand syndrome associated with left ventricular assist device.Lung perfusion and ventilation during implantation of left ventricular assist device as a strategy to avoid postoperative pulmonary complications and right ventricular failure.Assessment of right ventricular function in left ventricular assist device candidates.Pharmacotherapy for mechanical circulatory support: a comprehensive review.The pharmacotherapy implications of ventricular assist device in the patient with end-stage heart failure.Ventricular assist device infections.Intensive care of the pediatric ventricular assist device patient.Use of left ventricular assist device (HeartMate II): a Singapore experience.Depressed Exercise Peak Ejection Rate Detected on Ambulatory Radionuclide Monitoring Reflects End-Stage Cardiac Inotropic Reserve and Predicts Mortality in Ischaemic Cardiomyopathy.The Burden of Ventricular Arrhythmias Following Left Ventricular Assist Device Implantation.Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI.Variability in infection control measures for the percutaneous lead among programs implanting long-term ventricular assist devices in the United States.Neuron-specific enolase correlates to laboratory markers of haemolysis in patients on long-term circulatory support.Recurrent thrombosis after mechanical circulatory support.Thromboelastography (TEG)-based algorithm reduces blood product utilization in patients undergoing VAD implant.The risk of right ventricular failure with current continuous-flow left ventricular assist devices.Lactic Dehydrogenase in the In Vitro Evaluation of Hemolytic Properties of Ventricular Assist Device.Is there a difference in bleeding after left ventricular assist device implant: centrifugal versus axial?Decreased maximum clot firmness in rotational thromboelastometry (ROTEM®) is associated with bleeding during extracorporeal mechanical circulatory support.Severe hemolytic anemia caused by the NIPRO extracorporeal left ventricular assist device.Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome.
P2860
Q26864718-A980A755-18B0-4A46-8E63-95AD5F643C3AQ33626799-881B2CF6-9B87-40B2-9580-381573417E92Q34079591-E116FA00-BF61-4CDF-B60F-DD90FA6B23A5Q34149690-82C5130E-C36B-4009-8198-6C7350973304Q34604471-1DD2C749-3F98-4C08-864C-E01677A37B19Q35738389-359A2502-8209-4DFD-A49F-52494431C06BQ36112752-C3785585-56AE-4BF7-B45C-987FF5036DEBQ36125892-17D1C6D2-F900-420A-B571-616F5C26B5BFQ36289443-95A4B035-3808-497E-9291-631D31DA8DB0Q36289557-C20C9FD1-C03E-4552-BE45-3BF606294841Q36519201-4CC98D50-BF0C-4FEB-AD04-56A319441CF0Q37035825-78893D78-74C3-4A82-B7A9-CA3B6D24BD99Q37247399-3872E2F7-B189-4821-B7AE-3811EC4CB0EBQ37653938-C7A95B4A-2BA1-40CB-A337-FF9D632F4514Q37826020-4FA14100-E6F5-4761-9331-CAABF5848EF8Q37990893-D7CC3C1A-132D-4B16-A862-EEB670AF92DAQ38007865-8352F40A-3AB4-4AC0-9448-3D86073F5381Q38117319-0F7740AF-9542-477B-AE81-B75412660002Q38176058-1E25E920-4DFA-4CB1-998D-72F2AF736FCDQ38872391-10CD9924-D3EF-4C47-A41A-8BBCB9817A91Q39105822-63FC6082-61A4-4C2A-80F0-312B2DA04DA4Q39416821-C6CD6137-E536-4B28-8B07-B9C748D05AA6Q39513183-7C9E6AD6-84B1-4F52-8220-EBAA68B86FB2Q41625125-23F41FF0-5CC1-4181-A762-27B519782940Q42074456-F1ABC954-4C34-4A1A-A874-0E6D76AC20AAQ43443972-E473D536-16BF-4167-9C5B-4F7E4F039820Q47316522-FA7F63FD-3AD0-4A0C-8F11-6F07F2691878Q47908875-F7582935-E8F2-44E9-8D06-5B6AA7D0DAD9Q50057858-2A7D2420-478E-4253-892F-97D50C542397Q51352864-699C7084-55AA-46CB-9563-6EBCA6E57C4AQ51572700-C13268AD-1276-4ED9-8A32-650D0AE09840Q54362089-04EB5523-A203-4CB7-A40B-8133981BA7E8
P2860
Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Incidence and patterns of adve ...... ar assist device implantation.
@en
Incidence and patterns of adve ...... ar assist device implantation.
@nl
type
label
Incidence and patterns of adve ...... ar assist device implantation.
@en
Incidence and patterns of adve ...... ar assist device implantation.
@nl
prefLabel
Incidence and patterns of adve ...... ar assist device implantation.
@en
Incidence and patterns of adve ...... ar assist device implantation.
@nl
P2093
P2860
P1476
Incidence and patterns of adve ...... ar assist device implantation.
@en
P2093
Christian A Bermudez
Elizabeth A Genovese
Jay K Bhama
Jeffrey J Teuteberg
Kathleen L Lockard
Marc A Simon
Mary Amanda Dew
Michael P Siegenthaler
Robert L Kormos
P2860
P304
P356
10.1016/J.ATHORACSUR.2009.06.028
P407
P577
2009-10-01T00:00:00Z